These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26714507)

  • 1. The footprints of relapsing malaria in southwest Delhi, India.
    Savargaonkar D; Nagpal BN; Srivastava B; Anvikar AR; Valecha N
    J Vector Borne Dis; 2015 Dec; 52(4):287-92. PubMed ID: 26714507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
    Betuela I; Rosanas-Urgell A; Kiniboro B; Stanisic DI; Samol L; de Lazzari E; Del Portillo HA; Siba P; Alonso PL; Bassat Q; Mueller I
    J Infect Dis; 2012 Dec; 206(11):1771-80. PubMed ID: 22966124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria surveillance--United States, 2009.
    Mali S; Tan KR; Arguin PM; ;
    MMWR Surveill Summ; 2011 Apr; 60(3):1-15. PubMed ID: 21508921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
    Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
    Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India.
    Dua VK; Sharma VP
    Ann Trop Med Parasitol; 2001 Oct; 95(7):655-9. PubMed ID: 11784418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the efficacy of 8 weeks of primaquine for the prevention of relapse in vivax malaria patients using SSCP-PCR and sequencing in South and South-East Iran, 2008-2011.
    Miahipour A; Keshavarz H; Heidari A; Raeisi A; Rezaeian M; Rezaei S
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):420-6. PubMed ID: 23694816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E; Regev-Yochay G
    Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
    Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
    Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
    Goller JL; Jolley D; Ringwald P; Biggs BA
    Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of malaria in Aligarh.
    Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
    J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria: anti malarial resistance and policy ramifications and challenges.
    Kshirsagar NA
    J Postgrad Med; 2006; 52(4):291-3. PubMed ID: 17102549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in the therapy for imported malaria in the United States.
    Singh K; Wester WC; Trenholme GM
    Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 5 day radical treatment of primaquine in Plasmodium vivax cases at the BHEL industrial complex, Hardwar (U.P.).
    Sinha S; Dua VK; Sharma VP
    Indian J Malariol; 1989 Jun; 26(2):83-6. PubMed ID: 2676618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria in a tertiary hospital in Singapore--clinical presentation, treatment and outcome: an eleven year retrospective review.
    Chung SJ; Low JG; Wijaya L
    Travel Med Infect Dis; 2014; 12(6 Pt B):738-44. PubMed ID: 25467088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days.
    Carmona-Fonseca J; Maestre A
    Acta Trop; 2009 Nov; 112(2):188-92. PubMed ID: 19653988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.